• Norsk
  • English

Tweets

Inven2 @Inven2as Follow Inven2 har fått tildelt fem millioner i presåkornkapital https://t.co/JxzleqmV6T https://t.co/pKFV1zRMnb 4 months 2 weeks ago Reply Retweet Favorite
Inven2 @Inven2as Follow Gir syke barn mulighet til ny behandling. Les om Heidi Glosli og den kliniske forskningsposten for barn ved… https://t.co/OIINUxUMPQ 4 months 3 weeks ago Reply Retweet Favorite
Inven2 @Inven2as Follow RT : Hvilke forventninger har du som ekstern aktør til det nye livsvitenskapsbygget ? Meld deg på innspillskonfe… https://t.co/PAoA4szuyq 4 months 3 weeks ago Reply Retweet Favorite
Hanne M Kristensen @HanneMKris Follow Utrolig kult! Er vel lenge til neste gang vi ser ni statsministre i labfrakk diskutere helseteknologi på denne måte… https://t.co/jbnLiuIi6M 4 months 3 weeks ago Reply Retweet Favorite
Inven2 @Inven2as Follow https://t.co/RrgwN7LZXY 4 months 3 weeks ago Reply Retweet Favorite
Inven2 @Inven2as Follow Are you a scientist working on health-related topics? Do you have an idea for a new solution or technology with inn… https://t.co/IoAvOvM6Te 4 months 3 weeks ago Reply Retweet Favorite
Inven2 @Inven2as Follow How can we develop more efficient influenza vaccines that can be rapidly produced to counter an emerging pandemic t… https://t.co/bL6S3hWN5h 4 months 3 weeks ago Reply Retweet Favorite
The Lab of Adaptive Immunity and Homeostasis @AndersenJT Follow Species-specific binding of albumin to FcRn challenges preclinical development. Humanized FcRn transgenic mice may… https://t.co/5WbFMGaSGs 5 months 2 hours ago Reply Retweet Favorite
Inven2 @Inven2as Follow RT : Genterapi gir nye behandlingsmuligheter mot sykdom! Vi har skrevet blogg om våre nyeste funn som kan bane vei for m… https://t.co/oDK2DXt1jC 5 months 4 hours ago Reply Retweet Favorite
The Lab of Adaptive Immunity and Homeostasis @AndersenJT Follow Genterapi gir nye behandlingsmuligheter mot sykdom! Vi har skrevet blogg om våre nyeste funn som kan bane vei for m… https://t.co/oDK2DXt1jC 5 months 20 hours ago Reply Retweet Favorite
Inven2 @Inven2as Follow Vår porteføljebedrift leverer strømstyring til private el-bilkunder, næringsbygg, borettslag og kommune… https://t.co/BQ6FnUoWeW 5 months 1 day ago Reply Retweet Favorite
Ole Kr Hjelstuen @OKHjelstuen Follow Nyttig fra Vaccibody og Agnethe 👍 heier! https://t.co/gZsdIokrtc 5 months 1 day ago Reply Retweet Favorite
The Lab of Adaptive Immunity and Homeostasis @AndersenJT Follow An in-depth understanding of the structure-function relationship of antibodies has allowed us to develop a technolo… https://t.co/EaGeEcxGAA 5 months 2 days ago Reply Retweet Favorite
Inven2 @Inven2as Follow RT : How can antibodies give more efficient cancer drugs? Watch video from SPARK Norway, progra… https://t.co/0se3vm0ICf 5 months 2 days ago Reply Retweet Favorite
Inven2 @Inven2as Follow RT : Interested in successful models for academia–industry collaboration and how to advance early stage academic innovat… https://t.co/D50ubizHlg 5 months 2 days ago Reply Retweet Favorite
Inven2 @Inven2as Follow For 15 år siden ble norsk lovverk endret for å legge til rette for kommersialisering av universitetsforskning. Hva… https://t.co/9HPwgRxn0h 5 months 4 days ago Reply Retweet Favorite
Inven2 @Inven2as Follow Vi gratulerer som ny leder av Forskerforfundet ! https://t.co/6SOquYqLsQ 5 months 1 week ago Reply Retweet Favorite
Inven2 @Inven2as Follow RT : Remember the application deadline for the innovation programme SPARK Norway : Watch new videos with our SPA… https://t.co/ON45SJrPwp 5 months 1 week ago Reply Retweet Favorite
Inven2 @Inven2as Follow Heidi Glosli forteller om hvordan hun og kollegaer har jobbet for å bygge opp en egen klinisk forskningspost for ba… https://t.co/8bNlnX4LQr 5 months 1 week ago Reply Retweet Favorite
Inven2 @Inven2as Follow Lise Rødsten jobber med samarbeid mellom industri og forskning og forteller om hva gjør innen dette felte… https://t.co/f3CBP02ejg 5 months 1 week ago Reply Retweet Favorite

Pages